Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
Past hour
Any time
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
46m
Vertex Pharmaceuticals Inc. stock underperforms Thursday when compared to competitors despite daily gains
Supported by world-class markets data from Dow Jones and FactSet, and partnering with Automated Insights, MarketWatch ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Trending now
FBI: Attacker acted alone
Russian drone strike on Kyiv
Launches bid for governor
Home searched amid probe
‘Dinosaur highway’ tracks
Winter storm warnings
Suspect served as soldier
Broccoli recalled
Oldest Olympic champ dies
Italy summons Iran envoy
Most on-time airlines in ‘24
New rules for next Congress
To exit climate alliance
Pulls out of Glastonbury
Quake strikes Lake County
2025 Pro Bowl rosters
How to watch Quadrantids
Reports 1.1% sales drop
Israeli airstrikes in Gaza
'General Hospital’ actor dies
Golden Globes presenters
To settle Siri privacy suit
Weekly jobless claims fall
New NC gov. sworn in
Queens nightclub shooting
Montenegro mass shooting
Homemade bombs in Va.
Puerto Rico power restored
Russian gas to Europe halted
Hawaii fireworks explosion
Preinaugural rally in DC
Related topics
Vertex Pharmaceuticals
New York
Korsinsky
Feedback